The PI3K/Akt/mTOR pathway is primarily activated at different targets in diseases with BRAF and RAS mutations, and these specific combinations have been shown to induce thyroid cancer progression in mouse models [42]. The gene discussed is AKT1; the disease is thyroid gland carcinoma.